The heads of Mundfish, Gameram and AppMagic became consultants to GEM Capital

The GEM Capital team has expanded, according to VentureBeat. The advisory board of the investment group includes the CEOs of three companies at once: Mundfish, Gameram and AppMagic.

Robert Bagratuni, Philip Gladkov and Maxim Samorukov

New arrivals:

  • Mundfish CEO Robert Bagratuni became the chief consultant for PC and console games;
  • Gameram CEO Philip Gladkov, who previously also headed Pixonic Studio, took the position of chief consultant for mobile games;
  • Maxim Samorukov, CEO of AppMagic, took the chair of the chief analytics consultant.

"The arrival of Robert, Philip and Maxim at GEM Capital is not just the formation of an Advisory Board and the expansion of the composition of advisers. This is the reinforcement of our team with outstanding talents with a unique vision that will determine the future of investment in the gaming industry for many years to come. Philip has brilliant intelligence, a sharp mind and strategic flair, Maxim impresses with fantastic analytical skills and a mathematical approach to solving any problem, and Robert is a real marketing guru with encyclopedic knowledge of the PC and console market. Each of them brings unique skills and strategic vision that will undoubtedly take GEM Capital to a new, even higher level," Roman Gursky, Managing Director of GEM Capital, said in connection with the announcement.

GEM Capital is one of the most active investment funds in the gaming market. The group has supported more than 25 projects, in particular, at one time it invested in Mundfish with Gameram. GEM Capital announced its latest investment a week and a half ago — together with KRAFTON, The Games Fund, Behold Ventures and a number of other companies, it invested in the Red Rover Interactive studio, which is developing the post-apocalyptic PvP survival Project Coltrane.

According to VentureBeat, at the moment, GEM Capital's investment volume is estimated at about $ 150 million.

A source:

Write a comment...
Related news